Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin America

Fernández-Ávila D.G.; Barahona-Correa J.; Romero-Alvernia D.; Kowalski S.; Sapag A.; Cachafeiro-Vilar A.; Meléndez B.; Pastelín C.; Palleiro D.; Arrieta D.; Reyes G.; Pons-Estel G.J.; Then-Báez J.; Ugarte-Gil M.F.; Cardiel M.H.; Colman N.; Chávez N.; Burgos P.I.; Montufar R.; Sandino S.; Fuentes-Silva Y.J.; Soriano E.R. · Rheumatology International (2022) · DOI: 10.1007/s00296-021-05014-y

Resumen

The objective of our study was to describe knowledge, attitudes and practices of Latin-American rheumatology patients regarding management and follow-up of their disease during COVID-19 pandemic. A cross-sectional observational study was conducted using a digital anonymous survey. Rheumatic patients ≥ 18 years from non-English-speaking PANLAR countries were included. Our survey included 3502 rheumatic patients living in more than 19 Latin-American countries. Median age of patients was 45.8(36–55) years and the majority (88.9%) was female. Most frequently self-reported disease was rheumatoid arthritis (48.4%). At least one anti-rheumatic treatment was suspended by 23.4% of patients. Fear of contracting SARS-Cov2 (27.7%) and economic issues (25%) were the most common reasons for drug discontinuation. Self-rated disease activity increased from 30 (7–50) to 45 (10–70) points during the pandemic. Communication with their rheumatologist during the pandemic was required by 55.6% of patients, mainly by telephone calls (50.2%) and social network messages (47.8%). An adequate knowledge about COVID-19 was observed in 43% of patients. Patients with rheumatic diseases in Latin America were negatively affected by the COVID-19 pandemic. An increase in self-rated disease activity, a reduction in medication adherence, and hurdles for medical follow-up were reported. Teleconsultation was perceived as a valid alternative to in-person visits during the pandemic.

Instituciones: Universidad Científica del Sur